Cis-2-enoyl-coenzyme A reductase (NADPH)
RxNorm 391505
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 391505 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: Cis-2-enoyl-coenzyme A reductase (NADPH).
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
PT
Designated preferred name (PT):
Cis-2-enoyl-CoA reductase (NADPH)
(Atom ID: 1632022)
SY
Synonym (SY):
Cis-2-enoyl-coenzyme A reductase (NADPH)
(Atom ID: 5939406)
SY
Synonym (SY):
Cis-2-enoyl-coenzyme A reductase (reduced nicotinamide adenine dinucleotide phosphate)
(Atom ID: 5939407)
FN